The study found that tripartite motif-containing protein 34 (TRIM34) plays a crucial role in decreasing ferroptosis in HCC cells, suggesting its potential as a therapeutic target to enhance sensitivity to ferroptosis-inducing treatments. This evidence concerns the gene TRIM34 and hepatocellular carcinoma.